Lilly to Participate in Credit Suisse 28th Annual Healthcare Conference

On November 4, 2019 Eli Lilly and Company (NYSE:LLY) reported that it will participate in the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019 (Press release, Eli Lilly, NOV 4, 2019, View Source [SID1234550233]). Anne White, president of Lilly Oncology, Kimberly Blackwell, M.D., vice president, early phase clinical research, and Maura Dickler, M.D., vice president, oncology late phase development, will participate in a fireside chat at 10:35 a.m., Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.